Skip to main content
Fig. 2 | BMC Women's Health

Fig. 2

From: Integrating traditional biomarkers and emerging predictors to assess neoadjuvant chemotherapy efficacy in breast cancer: a multifactorial analysis of Ki-67, CDK4, EGFR, TILs and ctDNA

Fig. 2

Expression of C-erbB-2 protein detected by immunohistochemistry ( EnVision method, low magnification) and amplification of HER2 gene detected by fluorescence in situ hybridization ( FISH method × 1 000): Fig. ① C-erbB-2 0; Fig. ② shows C-erbB-2 1 + ; Fig. ③ C-erbB-2 + ; Fig. ④ C-erbB-2 3 + ; Fig. ⑤ HER2 gene amplification in control group, Fig. ⑥ HER2 gene amplification in experimental group, and Fig. ⑤ is from the same case

Back to article page

BMC Women's Health

ISSN: 1472-6874

Contact us